Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.82 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Lexicon Pharmaceuticals (LXRX) recorded Return on Capital Employed [ROCE] of -22.27% in Q2 2026, up 29.92 percentage points from -52.19% a year earlier but down 11.11 percentage points from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Lexicon Pharmaceuticals reported Return on Capital Employed [ROCE] of -22.15%, up 67.99 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -4.04 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -90.14% in FY2024 (+5.11 pp), -95.25% in FY2023 (-24.51 pp), -70.74% in FY2022 (-11.99 pp) and -58.76% in FY2021 (-40.65 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from -94.72% in Q1 2025 to -11.16% in Q1 2026 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for five consecutive quarters, with an average year-over-year change of +19.50 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 83.56 percentage points in Q1 2026, against a drop of 116.10 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -11.16% (Q1 2026), -28.01% (Q4 2025) and -34.46% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Lexicon Pharmaceuticals 813.30 Mn 239.86 Mn 653,000.00 -22.27%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.27%
Mar 31, 2026 -11.16%
Dec 31, 2025 -28.01%
Sep 30, 2025 -34.46%
Jun 30, 2025 -52.19%
Mar 31, 2025 -94.72%
Dec 31, 2024 -74.52%
Sep 30, 2024 -67.84%
Jun 30, 2024 -53.63%
Mar 31, 2024 -62.00%
Dec 31, 2023 -77.57%
Sep 30, 2023 -58.75%
Jun 30, 2023 -60.28%
Mar 31, 2023 -68.63%
Dec 31, 2022 -59.33%
Sep 30, 2022 -71.74%
Jun 30, 2022 -89.10%
Mar 31, 2022 -76.19%
Dec 31, 2021 -65.73%
Sep 30, 2021 -50.25%
API Access

Lexicon Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LXRX&period=max&api_key=YOUR_API_KEY